News
ProKidney Corp. (Nasdaq: PROK) ('ProKidney” or the 'Company”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that senior members ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback